Table 4.
Dosage form | Detection Method (Wavelength) | Total chromatographic peak number | Chromatographic peak identification | Reference |
---|---|---|---|---|
Wuzi Yanzong Wan | HPLC (250 nm) | 5 | Hyperoside, Verbascoside, Kaempferide, Schisandrin | Chinese Pharmacopoeia (2020) |
HPLC (254 nm) | 18 | Hyperoside, Isoquercitrin, Kaempferol, Verbascoside, Astragalin, Gomisin A | 27 | |
HPLC-DAD (254 nm) | 24 | Gallic acid, geniposidic acid, Chlorogenic acid, Hyperoside, Isoquercitrin, Verbascoside, Kaempferol-3-rutinoside, Isoverbascoside | 28 | |
HPLC/PDA (360, 250 nm) | 11 | Chlorogenic acid, Hyperoside, Quercetin, Kaempferide,Verbascoside, Astragalin, Schisandrin, Gomisin A, Schisandrin A, Schisandrin B | 23 | |
HPLC/PDA (254 nm) | 10 | Chlorogenic acid, Hyperoside, Verbascoside, Kaempferol, Schisandrin, Schisandrin A, Schisandrin B, Astragalin, Quercetin | 29 |
Notes: HPLC: high performance liquid chromatography; HPLC-DAD: high-performance liquid chromatography-diode array detection; HPLC/PDA: high-performance liquid chromatography- photo-diode array.